Eagle Health Investments LP - Q2 2022 holdings

$429 Million is the total value of Eagle Health Investments LP's 28 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 0.0% .

 Value Shares↓ Weighting
UTHR  UNITED THERAPEUTICS CORP DEL$37,523,000
+31.3%
159,2380.0%8.75%
+24.3%
AXNX  AXONICS INC$14,534,000
-9.5%
256,4650.0%3.39%
-14.3%
BPMC  BLUEPRINT MEDICINES CORP$8,615,000
-20.9%
170,5510.0%2.01%
-25.1%
GH  GUARDANT HEALTH INC$6,130,000
-39.1%
151,9600.0%1.43%
-42.4%
CMAX  CAREMAX INC$2,595,000
-51.4%
714,7550.0%0.60%
-54.0%
BEAM  BEAM THERAPEUTICS INC$1,119,000
-32.4%
28,9000.0%0.26%
-36.0%
ARVN  ARVINAS INC$968,000
-37.5%
23,0000.0%0.23%
-40.7%
LYEL  LYELL IMMUNOPHARMA INC$652,000
+29.1%
100,0000.0%0.15%
+22.6%
OLK  OLINK HLDG ABsponsored ads$608,000
-13.9%
40,0000.0%0.14%
-18.4%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-08-11
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
IQVIA HLDGS INC12Q3 20239.6%
UNITED THERAPEUTICS CORP DEL12Q3 20238.7%
ALNYLAM PHARMACEUTICALS INC12Q3 20238.5%
NATERA INC12Q3 20238.5%
ARGENX SE12Q3 20237.0%
DEXCOM INC12Q3 20235.7%
OUTSET MED INC12Q3 20237.3%
AGIOS PHARMACEUTICALS INC12Q3 20237.2%
ADAPTIVE BIOTECHNOLOGIES COR12Q3 20235.1%
GUARDANT HEALTH INC12Q3 20233.8%

View Eagle Health Investments LP's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-05-14
13F-HR2024-02-12
13F-HR2023-10-27
13F-HR2023-08-14
13F-HR2023-05-12
13F-HR2023-02-13
13F-HR2022-11-14
13F-HR2022-08-11
13F-HR2022-05-12
13F-HR2022-02-10

View Eagle Health Investments LP's complete filings history.

Compare quarters

Export Eagle Health Investments LP's holdings